Xequte User Forums
Xequte User Forums
Profile | Join | Active Topics | Search | Forum FAQ
Forum membership is Free!  Click Join to sign-up
Username:
 Password:
Save Password
Forgot your Password?

     
Forum Tips
» This forum is for users to discuss their software problems and suggestions for improvement.  Remember that only a tiny percentage of our users experience such problems (To be precise less than 0.7% have ever posted on this forum)
» Include your software version number (as displayed in the About Box)
» Check the FAQ before posting as most common questions have already been answered
» You don't need to also e-mail us separately as our support team will respond to all questions on this forum
 
 All Forums
 Xequte User Forums
 MailList King
 trop 2 adc		  New Topic  Reply to Topic
 Printer Friendly
Author Previous Topic Topic Next Topic  

catalinagarcia

3 Posts
Posted - Oct 17 2024 :  23:12:24  Show Profile  Reply
A growing body of evidence suggests that TROP2 is a promising molecular target for the treatment of various malignancies. As novel targeted therapy with great potential, antibody-drug conjugates (ADCs) targeting a specific antigen inherit superiorities of antibody with the drug module, and more remarkably, expand the therapeutic window. For more information about trop 2 adc: https://www.creative-biolabs.com/adc/adc-development-services-targeting-trop2.htm
  Previous Topic Topic Next Topic  
 New Topic  Reply to Topic
 Printer Friendly
Jump To: